Candel Therapeutics, Inc. CADL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$8.86M-220% | -$29.5M-110% | -$11.27M-5.9% | -$4.8M+78.4% | $7.38M+190% | ||
| $149K-39.2% | $163K-33.5% | $200K0.0% | $200K0.0% | $245K-2.4% | ||
| $1.45M+362% | $1.29M+3.7% | $1.16M-1.8% | $1.05M-43.0% | $314K-69.9% | ||
| -$18.04M-109% | -$10.57M-81.8% | -$10.24M-55.7% | -$8.89M-43.4% | -$8.62M-2.1% | ||
| $675K+22,400% | $409K+13,533% | $144K— | $31K+417% | $3K-57.1% | ||
| -$675K-22,400% | -$409K-13,533% | -$117K— | -$31K-417% | -$3K+57.1% | ||
| $93.82M+5,117% | $43.9M-52.2% | $0-100% | $17.44M+797% | -$1.87M-49.0% | ||
| $75.1M+816% | $32.92M-61.8% | -$13.72M-180% | $8.52M+300% | -$10.49M-8.1% | ||
| -$18.71M-117% | -$10.98M-88.7% | -$10.38M-57.9% | -$8.92M-43.8% | -$8.62M-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Candel Therapeutics, Inc. generate?
- Candel Therapeutics, Inc. (CADL) generated -$47.7M in operating cash flow over the trailing twelve months.
- What is Candel Therapeutics, Inc.'s free cash flow?
- After $1.3M of capital expenditures, Candel Therapeutics, Inc.'s free cash flow was -$49.0M over the trailing twelve months, down 80.0% year over year.
- Where does Candel Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.